Locations:
Search IconSearch

Research

Lab research
December 16, 2022/Cancer/Research

Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors

Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia

Dr. Brian T. Hill
December 14, 2022/Cancer/Research

Precision Medicine Approach Needed to Treat Subgroups of Diffuse Large B-Cell Lymphoma

Distinct molecular features found in five subtypes of disease

CAR T-cells
December 13, 2022/Cancer/Research

Study Provides Insights about Chemorefractory Diffuse Large B-Cell Lymphoma

Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy

22-CNR-3405917-CQD-Hero-650×450 blood clot
December 12, 2022/Cancer/Research

Study Finds Biomarkers of Complications in Patients with Cancer Diagnosed with COVID-19

Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-CNR-3344410-CQD-Hero-650×450 Dr Gerds Momentum trial
December 9, 2022/Cancer/Research

Sustained Response Observed in MOMENTUM Trial of Patients with Myelofibrosis

Study matches momelotinib against danazol

breast cancer radiation
November 3, 2022/Cancer/Research

High Rates of Breast Cancer Recurrence after Intraoperative Radiation Therapy

Research supports national guidelines for early-stage breast cancer

melanoma
November 2, 2022/Cancer/Research

Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma

Timing of adjuvant immunotherapy unclear for maximum overall survival

22-CNR-3290514-CQD-Hero-650×450 lung cancer
October 27, 2022/Cancer/Research

Higher-dose Stereotactic Radiotherapy Achieves Better Control for Many Aggressive Lung Tumors

Treatment decision must be balanced against toxicity concerns

22-CNR-3290543-CQD-Hero-650×450 throat cancer
October 26, 2022/Cancer/Research

Predicting Overall Survival in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Genomic adjusted radiation dose guides treatment decision making

BackPage 8 of 26Next

Advertisement

Ad